Cargando…

Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases

Immune axonal neuropathies are a particular group of immune-mediated neuropathies that occasionally accompany systemic autoimmune rheumatic diseases such as connective tissue dissorders and primary systemic vasculitides. Apart from vasculitis of vasa nervorum, various other mechanisms are involved i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tulbă, Delia, Popescu, Bogdan Ovidiu, Manole, Emilia, Băicuș, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079948/
https://www.ncbi.nlm.nih.gov/pubmed/33935704
http://dx.doi.org/10.3389/fphar.2021.610585
_version_ 1783685326117535744
author Tulbă, Delia
Popescu, Bogdan Ovidiu
Manole, Emilia
Băicuș, Cristian
author_facet Tulbă, Delia
Popescu, Bogdan Ovidiu
Manole, Emilia
Băicuș, Cristian
author_sort Tulbă, Delia
collection PubMed
description Immune axonal neuropathies are a particular group of immune-mediated neuropathies that occasionally accompany systemic autoimmune rheumatic diseases such as connective tissue dissorders and primary systemic vasculitides. Apart from vasculitis of vasa nervorum, various other mechanisms are involved in their pathogenesis, with possible therapeutic implications. Immune axonal neuropathies have highly heterogeneous clinical presentation and course, ranging from mild chronic distal sensorimotor polyneuropathy to severe subacute mononeuritis multiplex with rapid progression and constitutional symptoms such as fever, malaise, weight loss and night sweats, underpinning a vasculitic process. Sensory neuronopathy (ganglionopathy), small fiber neuropathy (sensory and/or autonomic), axonal variants of Guillain-Barré syndrome and cranial neuropathies have also been reported. In contrast to demyelinating neuropathies, immune axonal neuropathies show absent or reduced nerve amplitudes with normal latencies and conduction velocities on nerve conduction studies. Diagnosis and initiation of treatment are often delayed, leading to accumulating disability. Considering the lack of validated diagnostic criteria and evidence-based treatment protocols for immune axonal neuropathies, this review offers a comprehensive perspective on etiopathogenesis, clinical and paraclinical findings as well as therapy guidance for assisting the clinician in approaching these patients. High quality clinical research is required in order to provide indications and follow up rules for treatment in immune axonal neuropathies related to systemic autoimmune rheumatic diseases.
format Online
Article
Text
id pubmed-8079948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80799482021-04-29 Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases Tulbă, Delia Popescu, Bogdan Ovidiu Manole, Emilia Băicuș, Cristian Front Pharmacol Pharmacology Immune axonal neuropathies are a particular group of immune-mediated neuropathies that occasionally accompany systemic autoimmune rheumatic diseases such as connective tissue dissorders and primary systemic vasculitides. Apart from vasculitis of vasa nervorum, various other mechanisms are involved in their pathogenesis, with possible therapeutic implications. Immune axonal neuropathies have highly heterogeneous clinical presentation and course, ranging from mild chronic distal sensorimotor polyneuropathy to severe subacute mononeuritis multiplex with rapid progression and constitutional symptoms such as fever, malaise, weight loss and night sweats, underpinning a vasculitic process. Sensory neuronopathy (ganglionopathy), small fiber neuropathy (sensory and/or autonomic), axonal variants of Guillain-Barré syndrome and cranial neuropathies have also been reported. In contrast to demyelinating neuropathies, immune axonal neuropathies show absent or reduced nerve amplitudes with normal latencies and conduction velocities on nerve conduction studies. Diagnosis and initiation of treatment are often delayed, leading to accumulating disability. Considering the lack of validated diagnostic criteria and evidence-based treatment protocols for immune axonal neuropathies, this review offers a comprehensive perspective on etiopathogenesis, clinical and paraclinical findings as well as therapy guidance for assisting the clinician in approaching these patients. High quality clinical research is required in order to provide indications and follow up rules for treatment in immune axonal neuropathies related to systemic autoimmune rheumatic diseases. Frontiers Media S.A. 2021-04-14 /pmc/articles/PMC8079948/ /pubmed/33935704 http://dx.doi.org/10.3389/fphar.2021.610585 Text en Copyright © 2021 Tulbă, Popescu, Manole and Băicuș. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tulbă, Delia
Popescu, Bogdan Ovidiu
Manole, Emilia
Băicuș, Cristian
Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title_full Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title_fullStr Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title_full_unstemmed Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title_short Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
title_sort immune axonal neuropathies associated with systemic autoimmune rheumatic diseases
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079948/
https://www.ncbi.nlm.nih.gov/pubmed/33935704
http://dx.doi.org/10.3389/fphar.2021.610585
work_keys_str_mv AT tulbadelia immuneaxonalneuropathiesassociatedwithsystemicautoimmunerheumaticdiseases
AT popescubogdanovidiu immuneaxonalneuropathiesassociatedwithsystemicautoimmunerheumaticdiseases
AT manoleemilia immuneaxonalneuropathiesassociatedwithsystemicautoimmunerheumaticdiseases
AT baicuscristian immuneaxonalneuropathiesassociatedwithsystemicautoimmunerheumaticdiseases